Biomarkers of cardiovascular disease as risk factors for age-related macular degeneration

Ophthalmology

Volumn 112, Issue 12, 2005, Pages 2076-2080

  Vine, Andrew K ^a,c   Stader, Jacqueline ^a   Branham, Kari ^a   Musch, David C ^a   Swaroop, Anand ^a,b  

^a UNIVERSITY OF MICHIGAN   (United States)

^b UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; HOMOCYSTEINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;

AGED; ANAMNESIS; ARTICLE; ATHEROSCLEROSIS; BLOOD LEVEL; CARDIOVASCULAR DISEASE; CHRONIC INFLAMMATION; CONTROLLED STUDY; DIABETES MELLITUS; DRUG USE; FEMALE; GENETIC ANALYSIS; HUMAN; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA MACULA AGE RELATED DEGENERATION; RISK FACTOR; SEX DIFFERENCE; SMOKING; VITAMIN SUPPLEMENTATION;

AGED; AGED, 80 AND OVER; ATHEROSCLEROSIS; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; FEMALE; FLUORESCEIN ANGIOGRAPHY; HOMOCYSTEINE; HUMANS; INFLAMMATION; MACULAR DEGENERATION; MALE; MIDDLE AGED; NEPHELOMETRY AND TURBIDIMETRY; RISK FACTORS;

EID: 28344438168     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2005.07.004     Document Type: Article

References (47)

1. R. Klein, B.E. Klein, K.L. Linton Prevalence of age-related maculopathy. The Beaver Dam Eye Study Ophthalmology 99 1992 933 943
2. J.M. Seddon, U.A. Ajani, B.D. Mitchell Familial aggregation of age-related maculopathy Am J Ophthalmol 123 1997 199 206
3. C.C. Klaver, R.C. Wolfs, J.J. Assink Genetic risk of age-related maculopathy. Population-based familial aggregation study Arch Ophthalmol 116 1998 1646 1651
4. G.R. Abecasis, B.M. Yashar, Y. Zhao Age-related macular degeneration a high-resolution genome scan for susceptibility loci in a population enriched for late-stage disease Am J Hum Genet 74 2004 482 494
5. J.M. Seddon, W.C. Willett, F.E. Speizer, S.E. Hankinson A prospective study of cigarette smoking and age-related macular degeneration in women JAMA 276 1996 1141 1146
6. J.M. Seddon, J. Cote, N. Davis, B. Rosner Progression of age-related macular degeneration association with body mass index, wrist circumference, and waist-hip ratio Arch Ophthalmol 121 2003 785 792
7. Eye Disease Case-Control Study Group Risk factors for neovascular age-related macular degeneration Arch Ophthalmol 110 1992 1701 1708
8. J.R. Vingerling, I. Dielemans, M.L. Bots Age-related macular degeneration is associated with atherosclerosis. The Rotterdam Study Am J Epidemiol 142 1995 404 409
9. L. Hyman, A.P. Schachat, Q. He Hypertension, cardiovascular disease, and age-related macular degeneration Arch Ophthalmol 18 2000 351 358
10. W. Smith, P. Mitchell, S.R. Leeder, J.J. Wang Plasma fibrinogen levels, other cardiovascular risk factors, and age-related maculopathy the Blue Mountain Eye Study Arch Ophthalmol 116 1998 583 587
11. J.R. Vingerling, I. Dielemans, J.C. Witteman Macular degeneration and early menopause a case controlled study BMJ 310 1995 1570 1571
12. J.A. Mares-Perlman, W.E. Brady, R. Klein Dietary fat and age-related maculopathy Arch Ophthalmol 113 1995 743 748
13. Eye Disease Case-Control Study Group Antioxidant status and neovascular age-related macular degeneration Arch Ophthalmol 111 1993 104 109
14. J.A. Mares-Perlman, R. Klein, B.E. Klein Association of zinc and antioxidant nutrients with age-related maculopathy Arch Ophthalmol 114 1996 991 997
15. P. Libby, P.M. Ridker, A. Maseri Inflammation and atherosclerosis Circulation 105 2002 1135 1143
16. T.B. Harris, L. Ferrucci, R.P. Tracey Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly Am J Med 106 1999 506 512
17. P.M. Ridker, C.H. Hennekens, J.E. Burning, N. Rifai C-reactive protein and other markers of inflammation in prediction of cardiovascular disease in women N Engl J Med 342 2000 836 843
18. H. Refsum, P.M. Ueland, O. Nygard, S.E. Vollset Homocysteine and cardiovascular disease Annu Rev Med 49 1998 31 62
19. I.M. Graham, L.E. Daly, H.M. Refsum Plasma homocysteine as risk factor for vascular disease. The European Concerted Action Project JAMA 277 1997 1775 1781
20. J.B. Ubbink, W.J. Vermaak, A. van der Merwe, P.J. Becker The effect of blood sample aging and food consumption on plasma total homocysteine levels Clin Chim Acta 207 1992 119 128
21. P.M. Ueland, H. Refsum, S.P. Stabler Total homocysteine in plasma or serum methods and clinical applications Clin Chem 39 1993 1764 1779
22. N.L. Flattem, J.L. Marx, J. Gawoski Fluorescein interference with homocysteine testing Arch Ophthalmol 123 2005 114 116
23. N. Rifai, R.P. Tracy, P.M. Ridker Clinical efficacy of an automated high-sensitivity C-reactive protein assay Clin Chem 45 1999 2136 2141
24. D.H. Anderson, R.F. Mullins, G.S. Hageman, L.V. Johnson A role for local inflammation in the formation of drusen in the ageing eye Am J Ophthalmol 134 2002 411 431
25. S.W. Cousins, D.G. Espinosa-Heidmann, K.G. Csaky Monocyte activation in patients with age-related macular degeneration a biomarker of risk of choroidal neovascularization? Arch Ophthalmol 122 2004 1013 1018
26. H.L. Wilson, D.M. Schwartz, H.R. Bhatt Statin and aspirin therapy are associated with decreased rates of choroidal neovascularization among patients with age-related macular degeneration Am J Ophthalmol 137 2004 615 624
27. M.A. Albert, E. Danielson, N. Rifai Effect of statin therapy on C-reactive protein levels: the Pravastatin Inflammation/CRP Evaluation (PRINCE): a randomized trial and cohort study JAMA 286 2001 64 70
28. L.E. Bautista, I.A. Arenas, A. Penuela, L.X. Martinez Total plasma homocysteine level and risk of cardiovascular disease a meta-analysis of prospective cohort studies J Clin Epidemol 55 2002 882 887
29. Homocysteine Studies Collaboration Homocysteine and risk of ischemic heart disease and stroke a meta-analysis JAMA 288 2002 2015 2022
30. A.A. Mangoni, S.H. Jackson Homocysteine and cardiovascular disease current evidence and future prosects Am J Med 112 2002 556 565
31. J.E. Manson, J.M. Gaziano, A. Spelsberg A secondary prevention trial of antioxidant vitamins and cardiovascular disease in women rationale, design, and methods Ann Epidemiol 5 1995 261 269
32. VITATOPS Trial Study Group The VITATOPS (Vitamins to Prevent Stroke) Trial rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischemic attack or stroke Cerebrovasc Dis 13 2002 120 126
33. G. Malek, C.M. Li, C. Guidry Apolipoprotein B in cholesterol-containing drusen and basal deposits of human eyes with age-related maculopathy Am J Pathol 162 2003 413 425
34. S. Schmidt, C. Klaver, A. Saunders A pooled case-control study of the apolipoprotein E (APOE) gene in age-related maculopathy Ophthalmic Genet 23 2002 209 223
35. R.A. Heuberger, A.I. Fisher, P.F. Jacques Relation of blood homocysteine and its nutritional determinants to age-related maculopathy in the third National Health and Nutrition Examination Survey Am J Clin Nutr 76 2002 897 902
36. R. Axer-Siegel, D. Bourla, R. Ehrlich Association of neovascular age-related macular degeneration and hyperhomocysteinemia Am J Ophthalmol 137 2004 84 89
37. R. Klein, B.E. Klein, E.K. Marino Early age-related maculopathy in the Cardiovascular Health Study Ophthalmology 110 2003 25 33
38. J.M. Seddon, G. Gensler, R.C. Milton Association between C-reactive protein and age-related macular degeneration JAMA 291 2004 704 710
39. E.M. Macy, T.E. Hayes, R.P. Tracy Variability in the measurement of C-reactive protein in healthy subjects implications for reference intervals and epidemiological applications Clin Chem 43 1997 52 58
40. A.B. Guttormsen, J. Schneede, T. Fiskerstrand Plasma concentrations of homocysteine and other aminothiol compounds are related to food intake in healthy human subjects J Nutr 124 1994 1934 1941
41. M.R. Malinow, S.S. Kang, L.M. Taylor Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease Circulation 79 1989 1180 1188
42. D.G. Hackam, S.S. Anand Emerging risk factors for atherosclerotic vascular disease a critical review of the evidence JAMA 290 2003 932 940
43. C.A. McCarty, B.N. Mukesh, R.H. Guymer Cholesterol-lowering medications reduce the risk of age-related maculopathy progression [letter] Med J Aust 175 2001 340
44. N.F. Hall, C.R. Gale, H. Syddall Risk of macular degeneration in users of statins cross sectional study BMJ 323 2001 375 376
45. R. van Leeuwen, J.R. Vingerling, A. Hofman Cholesterol lowering drugs and risk of age-related maculopathy prospective cohort study with cumulative exposure measurement BMJ 326 2003 255 256
46. R. Klein, B.E. Klein, S.C. Tomany Relation of statin use to the 5-year incidence and progression of age-related maculopathy Arch Ophthalmol 121 2003 1151 1155
47. R. Klein, B.E. Klein Do statins prevent age-related macular degeneration? Am J Ophthalmol 137 2004 747 749